 SAN CARLOS, Calif., Nov. 10, 2021 GLOBE NEWSWIRE -- ChemoCentryx, Inc., Nasdaq: CCXI, today announced that Thomas J. Schall, Ph.D., President and Chief Executive Officer, will participate in two upcoming investor conferences: 